What is Immunome's earnings yield?

Immunome (IMNM) reported earnings yield of -9.1% in Q1 2026.

How has Immunome's earnings yield changed year-over-year?

Immunome's earnings yield increased by 74.1% year-over-year, from -35.1% to -9.1%.

What is the long-term trend for Immunome's earnings yield?

Over 5 years (2020 to 2025), Immunome's earnings yield has grown at a -10.1% compound annual growth rate (CAGR), from -15.2% to -9%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Immunome IMNM Earnings yield

Earnings yield at other companies

PfizerPFE

6.8%—

Arcus BiosciencesRCUS

-13.6%-5.7pp

Nuvation BioNUVB

-9.8%-4.6pp

SELLAS Life Sciences Group, Inc.SLS

-3.9%-1.8pp

IDEAYA Biosciences, Inc.IDYA

-4.8%-2.1pp

ImmunityBio, Inc.IBRX

-10.8%-2.6pp

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Calculated from Immunome’s reported figures.

net income/market cap=-9.1%

Based on trailing twelve months.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's earnings yield?: Immunome (IMNM) reported earnings yield of -9.1% in Q1 2026.
How has Immunome's earnings yield changed year-over-year?: Immunome's earnings yield increased by 74.1% year-over-year, from -35.1% to -9.1%.
What is the long-term trend for Immunome's earnings yield?: Over 5 years (2020 to 2025), Immunome's earnings yield has grown at a -10.1% compound annual growth rate (CAGR), from -15.2% to -9%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.